These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34404557)

  • 21. Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.
    Perronne C; Adjagba A; Duclos P; Floret D; Houweling H; Le Goaster C; Lévy-Brühl D; Meyer F; Senouci K; Wichmann O
    Vaccine; 2016 Mar; 34(11):1325-30. PubMed ID: 26859237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.
    Hopman HA; Crowcroft NS; Cesuroglu T; Langley JM
    Vaccine; 2020 Mar; 38(11):2512-2518. PubMed ID: 32057578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups.
    Chocarro L; Duclos P; Senouci K; Southern J
    Expert Rev Vaccines; 2011 Sep; 10(9):1265-70. PubMed ID: 21919616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014.
    Takla A; Wichmann O; Carrillo-Santisteve P; Cotter S; Levy-Bruhl D; Paradowska-Stankiewicz I; Valentiner-Branth P; D'Ancona F;
    Euro Surveill; 2015 Mar; 20(9):. PubMed ID: 25764188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silent Consequences of COVID-19: Why It's Critical to Recover Routine Vaccination Rates Through Equitable Vaccine Policies and Practices.
    Skolnik A; Bhatti A; Larson A; Mitrovich R
    Ann Fam Med; 2021; 19(6):527-531. PubMed ID: 34376387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 28. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indicators to assess National Immunization Technical Advisory Groups (NITAGs).
    Blau J; Sadr-Azodi N; Clementz M; Abeysinghe N; Cakmak N; Duclos P; Janusz C; Jauregui B; Mihigo R; Mosina L; Takashima Y; Senouci K
    Vaccine; 2013 May; 31(23):2653-7. PubMed ID: 23398930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
    Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
    Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].
    Sell K; Saringer-Hamiti L; Geffert K; Strahwald B; Stratil JM; Pfadenhauer LM
    Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():1-12. PubMed ID: 34474991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination policies of immigrants in the EU/EEA Member States-the measles immunization example.
    Bica MA; Clemens R
    Eur J Public Health; 2018 Jun; 28(3):439-444. PubMed ID: 29136141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
    Ultsch B; Damm O; Beutels P; Bilcke J; Brüggenjürgen B; Gerber-Grote A; Greiner W; Hanquet G; Hutubessy R; Jit M; Knol M; von Kries R; Kuhlmann A; Levy-Bruhl D; Perleth M; Postma M; Salo H; Siebert U; Wasem J; Wichmann O
    Pharmacoeconomics; 2016 Mar; 34(3):227-44. PubMed ID: 26477039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
    Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs.
    Ba-Nguz A; Adjagba A; Wisnu Hendrarto T; Sewankambo NK; Nalwadda C; Kisakye A
    J Infect Dis; 2017 Jul; 216(suppl_1):S109-S113. PubMed ID: 28838176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
    Francis-Oliviero F; Bozoki S; Micsik A; Kieny MP; Lelièvre JD
    Vaccine; 2021 Oct; 39(44):6539-6544. PubMed ID: 34598823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.
    Levin A; Boonstoppel L; Brenzel L; Griffiths U; Hutubessy R; Jit M; Mogasale V; Pallas S; Resch S; Suharlim C; Yeung KHT
    BMC Med; 2022 Mar; 20(1):88. PubMed ID: 35255920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.